A team of researchers from Scripps Research and Janssen Research & Development LLC has discovered an orally active small molecule that neutralizes influenza A group 1 viruses, the most common flu strains. Scientists uncovered the potential therapy in a large chemical library and optimized lead compounds to produce JNJ-4796. Now they have proven its effectiveness against influenza in mice.